India Globalization Capital Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IGC | ZTS | TAK | UTHR | NBIX |
| Company | India Globalization Capital Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.4626 | 149.24 | 13.32 | 233.61 | 140.89 |
| High | 0.4688 | 151.74 | 13.33 | 241.00 | 144.70 |
| Low | 0.4130 | 148.75 | 13.21 | 233.27 | 138.01 |
| Last | 0.4390 | 150.88 | 13.23 | 237.00 | 138.97 |
| Change | -0.0176 | +1.32 | -0.15 | +2.53 | -1.12 |
| % Change | -3.85% | +0.88% | -1.12% | +1.08% | -0.80% |
| Volume | 448,300 | 3,640,400 | 924,500 | 671,000 | 927,900 |
| 20-Day Average Volume | 1,697,770 | 4,103,280 | 1,763,520 | 541,550 | 814,105 |
| Previous Close | 0.4566 | 149.56 | 13.38 | 234.47 | 140.09 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5156 | 158.66 | 13.48 | 234.63 | 136.56 |
| 20-Day Raw Stochastic | 11.95% | 23.08% | 9.52% | 54.96% | 59.45% |
| 20-Day Relative Strength | 49.54% | 34.40% | 36.46% | 53.11% | 54.08% |
| Weighted Alpha | +8.32 | -20.05 | -20.66 | +5.07 | +39.67 |
| Today's Opinion | 88% Buy | 88% Sell | 100% Sell | 80% Buy | 96% Buy |
| Previous Opinion | 88% Buy | 88% Sell | 100% Sell | 64% Buy | 96% Buy |
| Last Month's Opinion | 56% Buy | 40% Sell | 72% Sell | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -25.15% since 04/17/24 | -0.70% since 04/17/24 | +0.61% since 04/17/24 | +0.72% since 04/17/24 | +4.31% since 04/17/24 |
| Low | 0.4130 on 04/24/24 | 144.80 on 04/22/24 | 13.12 on 04/18/24 | 233.27 on 04/24/24 | 130.13 on 04/19/24 |
| High | 0.5700 on 04/18/24 | 153.67 on 04/18/24 | 13.41 on 04/23/24 | 241.00 on 04/24/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | +16.76% since 03/22/24 | -10.67% since 03/22/24 | -8.19% since 03/22/24 | -0.38% since 03/22/24 | -1.74% since 03/22/24 |
| Low | 0.3530 on 03/26/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 221.53 on 04/01/24 | 130.13 on 04/19/24 |
| High | 0.9099 on 04/04/24 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 250.89 on 03/26/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | +56.84% since 01/24/24 | -18.91% since 01/24/24 | -9.88% since 01/24/24 | +8.31% since 01/24/24 | -0.81% since 01/24/24 |
| Low | 0.2700 on 02/22/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 |
| High | 0.9099 on 04/04/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 250.89 on 03/26/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +39.37% since 10/24/23 | -9.72% since 10/24/23 | -9.26% since 10/24/23 | +4.30% since 10/24/23 | +27.20% since 10/24/23 |
| Low | 0.2501 on 12/20/23 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 208.62 on 02/08/24 | 103.63 on 11/10/23 |
| High | 0.9099 on 04/04/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 258.31 on 12/14/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,507 | 68,402,608 | 42,345,264 | 11,033,921 | 13,939,936 |
| Shares Outstanding, K | 66,813 | 457,359 | 3,164,818 | 47,059 | 99,507 |
| Annual Sales | 910,000 | 8,544,000,000 | 29,803,340,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -11,510,000 | 2,344,000,000 | 2,345,930,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 200,000 | 2,213,000,000 | 7,556,070,000 | 614,700,000 | 515,200,000 |
| Last Quarter Net Income | -5,590,000 | 525,000,000 | 718,900,000 | 217,100,000 | 147,700,000 |
| 60-Month Beta | 1.71 | 0.85 | 0.53 | 0.52 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 02/14/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 4.36 on 02/21/24 | 1.44 on 02/07/24 |
| Latest Earnings Date | 02/13/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.36 | 6.85 | 11.80 | 55.23 |